Arizona Bioscience News: ASU-developed HIV vaccine; Assessing Theranos; New tech for Yulex

July 16, 2015

By Matt Ellsworth

asuASU professor nears clinical trials on HIV vaccine / Arizona Republic

Human clinical trials are drawing closer for a new HIV vaccine developed by ASU virologist Bertram Jacobs, who is basing his approach on that for the smallpox vaccine.

Running A Few Tests On Theranos: Can Elizabeth Holmes Revolutionize Diagnostics? / Forbes

Matthew Herper of Forbes interviews business partners of Theranos, the rapid-blood-test startup that has been increasing its footprint in Arizona, and comes away impressed.

Clinical trials key to Alzheimer’s research / Your West Valley

Banner Sun Health Research Institute is recruiting volunteer participants for its clinical trials of potential diagnostics and treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases.

The Superplant That May Finally Topple the Rubber Monopoly / Wired

Using genetic technology to help develop new hybrids of the guayule plant, Maricopa-based Yulex continues its drive to develop a marketable alternative to hevea rubber for use both in tires and medical devices.

What Is A Clinical Trial? / KJZZ

Ashwini Roy-Choudhury, director of clinical research at the University of Arizona, explains the basics of clinical trials and what has changed in recent years in Arizona.

Medical Memory startup raises $2.1M for app to record patient-physician visits / Phoenix Business Journal

Phoenix-based Medical Memory LLC, a firm founded by a Barrow Neurological Institute neurosurgeon, has raised $2.1 million to further develop its mobile app to record and store physician-patient interactions.